Segall Bryant & Hamill’s Medidata Solutions, Inc. MDSO Stock Holding History

Segall Bryant & Hamill’s Portfolio MDSO Stock Details MDSO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	–	Sell	-10,698	Closed	-$979K	–	875
2019 Q3	$979K	Buy	10,698 +45	+0.4%	+$4.11K	0.02%	526
2019 Q2	$964K	Sell	10,653 -4,579	-30%	-$402K	0.01%	535
2019 Q1	$1.12M	Buy	15,232 +361	+2%	+$26.1K	0.02%	513
2018 Q4	$1M	Sell	14,871 -717	-5%	-$50.6K	0.02%	517
2018 Q3	$1.14M	Sell	15,588 -54	-0.3%	-$4.32K	0.02%	523
2018 Q2	$1.26M	Buy	+15,642	New	+$1.17M	0.02%	508

Other funds holding MDSO

WBC

Westpac Banking Corp Sydney, Australia $1.44B AUM 28.5% 1-Year Est. Return

Segall Bryant & Hamill's MDSO Position: Q4 2019 in Review

Segall Bryant & Hamill sold out of Medidata Solutions, Inc. (MDSO) in Q4 2019, closing a stake of 10,698 shares — an estimated $979K sold.

Segall Bryant & Hamill first reported a position in MDSO in Q2 2018 and held it in 6 quarters. The position peaked at $1.26M in Q2 2018. 1 fund tracked by Wall St. Rank holds MDSO as of Q4 2019.

Segall Bryant & Hamill reported no remaining Medidata Solutions, Inc. position as of Q4 2019 after selling out during the quarter.
Segall Bryant & Hamill sold 10,698 Medidata Solutions, Inc. shares in Q4 2019, an estimated $979K.
Segall Bryant & Hamill first reported a position in Medidata Solutions, Inc. in Q2 2018 and held it in 6 quarters.
Segall Bryant & Hamill's Medidata Solutions, Inc. position peaked at $1.26M in Q2 2018.
1 fund tracked by Wall St. Rank held Medidata Solutions, Inc. as of Q4 2019.

Based on Segall Bryant & Hamill's 13F filing for Q4 2019, filed 11 Feb 2020.